GILEAD SCIENCES, INC. Inventory, Noncurrent
GILEAD SCIENCES, INC. (GILD) had Inventory, Noncurrent of $2.35 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:InventoryNoncurrent · last filed 2026-08-06
- 2026-06-30: Inventory, Noncurrent $2.35B.
- 2026-03-31: Inventory, Noncurrent $2.42B.
- 2025-12-31: Inventory, Noncurrent $2.59B.
- 2025-09-30: Inventory, Noncurrent $2.60B.
| Period end | Inventory, Noncurrent |
|---|---|
| 2026-06-30 | $2.35B 10-Q · filed 2026-08-06 |
| 2026-03-31 | $2.42B 10-Q · filed 2026-05-07 |
| 2025-12-31 | $2.59B 10-Q · filed 2026-08-06 |
| 2025-09-30 | $2.60B 10-Q · filed 2025-11-07 |
| 2025-06-30 | $2.09B 10-Q · filed 2025-08-07 |
| 2025-03-31 | $2.02B 10-Q · filed 2025-05-07 |
| 2024-12-31 | $1.88B 10-K · filed 2026-02-24 |
| 2024-09-30 | $1.57B 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.36B 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.51B 10-Q · filed 2024-05-08 |
| 2023-12-31 | $1.58B 10-K · filed 2025-02-28 |
| 2023-09-30 | $1.54B 10-Q · filed 2023-11-07 |
| 2023-06-30 | $1.55B 10-Q · filed 2023-08-04 |
| 2023-03-31 | $1.43B 10-Q · filed 2023-05-03 |
| 2022-12-31 | $1.31B 10-K · filed 2024-02-23 |
| 2022-09-30 | $1.14B 10-Q · filed 2022-11-02 |
| 2022-06-30 | $1.09B 10-Q · filed 2022-08-08 |
| 2022-03-31 | $1.19B 10-Q · filed 2022-05-04 |
| 2021-12-31 | $1.12B 10-K · filed 2023-02-22 |
| 2021-09-30 | $1.12B 10-Q · filed 2021-11-03 |
| 2021-06-30 | $1.22B 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.22B 10-Q · filed 2021-05-06 |
| 2020-12-31 | $1.33B 10-K · filed 2022-02-23 |
| 2020-09-30 | $945.00M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $915.00M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $1.03B 10-Q · filed 2020-05-06 |
| 2019-12-31 | $1.15B 10-K · filed 2021-02-25 |
| 2019-09-30 | $1.68B 10-Q · filed 2019-11-05 |
| 2019-06-30 | $1.71B 10-Q · filed 2019-08-06 |
| 2019-03-31 | $1.73B 10-Q · filed 2019-05-08 |
| 2018-12-31 | $1.82B 10-K · filed 2020-02-25 |
| 2018-09-30 | $2.14B 10-Q · filed 2018-11-06 |
| 2018-06-30 | $1.97B 10-Q · filed 2018-08-06 |
| 2018-03-31 | $1.99B 10-Q · filed 2018-05-09 |
| 2017-12-31 | $2.10B 10-K · filed 2019-02-26 |
| 2017-09-30 | $2.03B 10-Q · filed 2017-11-07 |
| 2017-06-30 | $1.71B 10-Q · filed 2017-08-07 |
| 2017-03-31 | $1.69B 10-Q · filed 2017-05-10 |
| 2016-12-31 | $1.58B 10-K · filed 2018-02-27 |
| 2016-09-30 | $1.07B 10-Q · filed 2016-11-07 |
| 2016-06-30 | $941.00M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $851.00M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $771.00M 10-K · filed 2017-02-27 |
| 2015-09-30 | $576.00M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $465.00M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $332.00M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $489.00M 10-K · filed 2016-02-24 |
| 2013-12-31 | $359.00M 10-K · filed 2015-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |